Showing results (3571-3580 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|September 28, 2007
Angiogenesis inhibitors. Drug selectivity and target specificityGeorgios Kesisis, Henk Broxterman, Giuseppe GiacconeCurrent Pharmaceutical Design|September 28, 2007
The advance of dendrimers--a versatile targeting platform for gene/drug deliveryH S ParekhCurrent Pharmaceutical Design|July 18, 2006
Angiogenesis as a therapeutic target in arthritis: lessons from oncologyJohn Bainbridge, Branavan Sivakumar, Ewa PaleologCurrent Pharmaceutical Design|July 18, 2006
Antineovascular agents in the treatment of eye diseasesWolfram Eichler, Yousef Yafai, Peter Wiedemann, et al.Current Pharmaceutical Design|July 18, 2006
Natural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1)Dale G Nagle, Yu-Dong ZhouCurrent Pharmaceutical Design|July 18, 2006
Improving memory: a role for phosphodiesterasesA Blokland, R Schreiber, J PrickaertsCurrent Pharmaceutical Design|July 18, 2006
Inhibition of protein misfolding and aggregation by small rationally-designed peptidesL D Estrada, C SotoCurrent Pharmaceutical Design|July 18, 2006
Role of copper in prion diseases: deleterious or beneficial?Lorena Varela-Nallar, Alfonso González, Nibaldo C InestrosaCurrent Pharmaceutical Design|July 18, 2006
Toll-like receptors, cytokines and the immunotherapeutics of asthmaP Camateros, J Moisan, J Hénault, et al.Current Pharmaceutical Design|July 18, 2006
New frontiers in the therapeutic management of transplant rejectionJuan B De Sanctis, Jenny V Garmendia, Anna Radzioch, et al.Pageof 1,008